Valuation: Dermapharm Holding SE

Market Cap 2.12B 2.42B 1.98B 1.82B 3.4B 231B 3.49B 23.5B 9.19B 115B 9.07B 8.87B 396B P/E 2026 *
16.1x
P/E 2027 * 14.6x
Enterprise Value 2.91B 3.32B 2.72B 2.5B 4.67B 318B 4.79B 32.26B 12.62B 157B 12.45B 12.18B 544B EV / Sales 2026 *
2.41x
EV / Sales 2027 * 2.2x
Free-Float
10.7%
Yield 2026 *
2.37%
Yield 2027 * 2.62%
1 day+2.63%
1 week+6.33%
Current month-9.12%
1 month-8.83%
3 months-6.95%
6 months+21.39%
Current year+8.89%
1 week 39.95
Extreme 39.95
43.3
1 month 39.95
Extreme 39.95
47.65
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 01/08/2017
Director of Finance/CFO - 01/11/2022
Investor Relations Contact - 01/12/2018
Director TitleAgeSince
Chairman 70 01/08/2017
Director/Board Member 66 01/08/2017
Director/Board Member 77 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
14/05/26 Buy

Chairman

380,000 0.7670%
07/01/26 Buy 150 0.0003%
07/01/26 Buy 150 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.63%+6.33%+21.56%-2.21% 2.42B
-0.87%+4.04%+58.60%+163.92% 1,079B
-0.45%+3.87%+57.95%+52.18% 640B
+0.04%+3.95%+37.69%+74.54% 465B
-1.69%+8.81%+39.38%+34.26% 353B
-0.51%+3.51%+36.97%+43.76% 301B
+1.50%+3.40%+17.71%+18.77% 271B
+0.79%+5.81%-2.55%-36.02% 228B
-1.39%+5.90%+27.70%+64.00% 209B
-1.18%+1.83%+16.20%+72.69% 165B
Average -0.11%+4.78%+31.12%+48.59% 371.21B
Weighted average by Cap. -0.50%+4.70%+41.91%+78.78%

Financials

2026 *2027 *
Net sales 1.21B 1.38B 1.13B 1.04B 1.94B 132B 1.99B 13.38B 5.23B 65.19B 5.16B 5.05B 225B 1.25B 1.43B 1.17B 1.07B 2.01B 137B 2.06B 13.89B 5.43B 67.67B 5.36B 5.24B 234B
Net income 139M 158M 130M 119M 223M 15.15B 228M 1.54B 602M 7.5B 594M 581M 25.92B 155M 177M 145M 133M 249M 16.91B 255M 1.72B 672M 8.37B 663M 649M 28.93B
Net Debt 792M 901M 739M 679M 1.27B 86.34B 1.3B 8.77B 3.43B 42.73B 3.38B 3.31B 148B 636M 723M 593M 544M 1.02B 69.28B 1.04B 7.03B 2.75B 34.28B 2.72B 2.66B 119B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,503
Date Price Change Volume
29/07/26 €42.85 +2.63% 14,146
28/07/26 €41.75 +2.45% 23,019
27/07/26 €40.75 +1.12% 31,898
24/07/26 €40.30 -0.12% 16,423
23/07/26 €40.35 +0.12% 17,122
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
42.85EUR
Average target price
50.38EUR
Spread / Average Target
+17.56%

Quarterly revenue - Rate of surprise